Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions
Open Access
- 1 July 2000
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 267 (14) , 4495-4503
- https://doi.org/10.1046/j.1432-1327.2000.01498.x
Abstract
The ‘oxidation theory’ of atherosclerosis proposes that oxidation of low density lipoprotein (LDL) contributes to atherogenesis. Although the precise mechanisms of in vivo oxidation are widely unknown, increasing evidence suggests that myeloperoxidase (MPO, EC 1.11.1.7), a protein secreted by activated phagocytes, generates modified/oxidized (lipo)proteins via intermediate formation of hypochlorous acid (HOCl). In vitro generation of HOCl transforms lipoproteins into high uptake forms for macrophages giving rise to cholesterol‐engorged foam cells. To identify HOCl‐modified‐epitopes in human plaque tissues we have raised monoclonal antibodies (directed against human HOCl‐modified LDL) that do not cross‐react with other LDL modifications, i.e. peroxynitrite‐LDL, hemin‐LDL, Cu2+‐oxidized LDL, 4‐hydroxynonenal‐LDL, malondialdehyde‐LDL, glycated‐LDL, and acetylated‐LDL. The antibodies recognized a specific epitope present on various proteins after treatment with OCl− added as reagent or generated by the MPO/H2O2/halide system. Immunohistochemical studies revealed pronounced staining for HOCl‐modified‐epitopes in fibroatheroma (type V) and complicated (type VI) lesions, while no staining was observed in aortae of lesion‐prone location (type I). HOCl‐oxidation‐specific epitopes are detected in cells in the majority of atherosclerotic plaques but not in control segments. Staining was shown to be inside and outside monocytes/macrophages, endothelial cells, as well as in the extracellular matrix. A similar staining pattern using immunohistochemistry could be obtained for MPO. The colocalization of immunoreactive MPO and HOCl‐modified‐epitopes in serial sections of human atheroma (type IV), fibroatheroma (type V) and complicated (type VI) lesions provides further convincing evidence for MPO/H2O2/halide system‐mediated oxidation of (lipo)proteins under in vivo conditions. We propose that MPO could act as an important link between the development of atherosclerotic plaque in the artery wall and chronic inflammatory events.Keywords
This publication has 51 references indexed in Scilit:
- Effects of hypochlorite-modified low-density and high-density lipoproteins on intracellular Ca2+and plasma membrane Ca2+-ATPase activity of human plateletsCell Calcium, 1999
- Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's DiseaseExperimental Neurology, 1999
- Hypochlorite-Modified LDL: Chemotactic Potential and Chemokine Induction in Human MonocytesClinical Immunology and Immunopathology, 1998
- Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet functionPlatelets, 1998
- Interference of Carboxy-PTIO with Nitric Oxide- and Peroxynitrite-Mediated ReactionsFree Radical Biology & Medicine, 1997
- Bactericidal activity againstPseudomonas aeruginosa is acquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidaseCellular and Molecular Life Sciences, 1996
- Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and AscorbateArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994